Table 2.
Characteristics of the participants at baseline.
| Characteristics | Patients on the aGLP-1, n = 40 | Reference range |
|---|---|---|
| Age (years) | 27-75 (57.1)∗ | NA |
| Diabetes duration (years) | 11 ± 7.2 | NA |
| Body mass (kg) | 114.5 ± 26.4 | NA |
| BMI (kg/m2) | 40.9 ± 7.6 | <25 |
| WC (cm) | ||
| Men | 125.0 (116.0; 148.0) | <90 |
| Women | 116.0 (104.8; 132.5) | <84 |
| НbA1c (%) | 8.4 ± 1.3 | <6.5 |
| Glucose fasting (mmol/l) | 8.9 ± 1.8 | 3.3-6.1 |
| C-peptide fasting (ng/ml) | 3.5 ± 1.8 | 0.78-5.19 |
| C-peptide after test∗∗ (ng/ml) | 5.0 ± 2.8 | >9.9 (↑ on >50% from baseline) |
| НОМА-IR | 7.2 ± 4.4 | <2.77 |
| НОМА-β (%) | 35.7 (24.5; 61.0) | ≥100 |
| TC (mmol/l) | 5.2 ± 1.3 | <4.5 |
| HDL (mmol/l) | ||
| Men | 1.01 (0.79; 1.13) | >1.0 |
| Women | 1.07 (0.8; 1.3) | >1.2 |
| LDL (mmol/l) | 3.1 ± 1.1 | <1.8 |
| TG (mmol/l) | 1.9 (1.5; 3.2) | <1.7 |
| SBP (mm Hg) | 138.7 ± 14.7 | <140 |
| DBP (mm Hg) | 84.5 ± 8.4 | <85 |
∗Min-max (mean age). ∗∗2 hours after breakfast in the meal tolerance test.